Pharmaceuticals · RANCHO CUCAMONGA, CA, United States
$18.81
+1.95% (+$0.36)2026-05-26
Revenue$170.5M
Net Income$25.3M
EPS$0.51
Gross Margin50.0%
Market Cap$886.7M
Price Performance
Historical data including institutional events
Loading price data...
Company Profile
M
Mary Z. Luo
CEO & Executive Director
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.